Avant Genomics Secures $3M to Enhance Automated Liquid Biopsy Technology

Avant Genomics raises over $3 million to advance fully-automated liquid biopsy sample preparation for precise cancer detection.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here